Profiel
Elisabeth Sthengel is currently working as Manager-Design, Development & Clinical at Invent Medic Sweden AB since 2017.
Prior to this, she worked as Laboratory Manager at NOLabs AB.
Actieve functies van Elisabeth Sthengel
| Bedrijven | Functie | Begin |
|---|---|---|
| INVENT MEDIC SWEDEN AB | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 |
Eerdere bekende functies van Elisabeth Sthengel
| Bedrijven | Functie | Einde |
|---|---|---|
NOLabs AB
 NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INVENT MEDIC SWEDEN AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NOLabs AB
NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Health Technology |